Module 72 -- Testis genes

General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets:	2
Num genes:	311 (see 2540 additional genes for this module)
Num experiments:	721 (172 induced, 549 repressed)
Parent module:	None
Children modules:	None

Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
Testis_2
Testis_1

Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation	Category	P-value	Hits	Hits(%)	Module hits in category	Arrays in annotation	Arrays
Hematologic cancer and cell line (Stimulated PBMC)	Stimulated PBMC	8.0e-33	29	100	29	30	182
Macrophages (Stimulated PBMC)	Stimulated PBMC	8.0e-33	29	100	29	30	182
Lung tissue, cancer or cell line (Lung cancer*)	Lung cancer*	3.1e-26	155	28.2	549	276	1945
CNS tissue, cancer or cell line (Neuro tumors*)	Neuro tumors*	4.5e-23	67	12.2	549	85	1945
CNS cancer or cell line (Neuro tumors*)	Neuro tumors*	3.7e-22	64	11.6	549	81	1945
CNS tumor (Neuro tumors*)	Neuro tumors*	3.7e-22	64	11.6	549	81	1945
Cancer and cell line (Neuro tumors*)	Neuro tumors*	1.4e-21	66	12.0	549	86	1945
Cancer (Neuro tumors*)	Neuro tumors*	1.4e-21	66	12.0	549	86	1945
Cancer and cell line (Lung cancer*)	Lung cancer*	2.2e-19	134	24.4	549	252	1945
Cancer (Lung cancer*)	Lung cancer*	2.2e-19	134	24.4	549	252	1945
Non small cell lung cancer and cell line (Lung cancer*)	Lung cancer*	2.2e-18	114	20.7	549	205	1945
Non small cell lung cancer (Lung cancer*)	Lung cancer*	2.2e-18	114	20.7	549	205	1945
Lung cancer (Lung cancer*)	Lung cancer*	2.3e-16	123	22.4	549	238	1945
Lung cancer or cell line (Lung cancer*)	Lung cancer*	2.3e-16	123	22.4	549	238	1945
Prostate (Prostate cancer*)	Prostate cancer*	6.6e-11	59	10.7	549	101	1945
Chronic lymphocytic leukemia (B lymphoma)	B lymphoma	5.0e-09	29	44.6	65	46	245
Leukemia (B lymphoma)	B lymphoma	5.0e-09	29	44.6	65	46	245
Leukemia or leukemia cell line (B lymphoma)	B lymphoma	5.0e-09	29	44.6	65	46	245
Cancer and cell line (Liver cancer)	Liver cancer	1.6e-08	37	97.3	38	126	207
Lymphocytes (Various tumors)	Various tumors	1.2e-06	18	46.1	39	28	154
Monocytes (Various tumors)	Various tumors	1.2e-06	18	46.1	39	28	154
B. petrussis stimulated immune cells (Stimulated PBMC)	Stimulated PBMC	1.2e-06	19	95	20	67	144
Cancer and cell line (Gliomas*)	Gliomas*	1.2e-06	29	5.2	549	47	1945
Cancer (Gliomas*)	Gliomas*	1.2e-06	29	5.2	549	47	1945
CNS cancer or cell line (Gliomas*)	Gliomas*	1.2e-06	29	5.2	549	47	1945
CNS tissue, cancer or cell line (Gliomas*)	Gliomas*	1.2e-06	29	5.2	549	47	1945
CNS tumor (Gliomas*)	Gliomas*	1.2e-06	29	5.2	549	47	1945
Hematologic cancer and cell line (Various tumors)	Various tumors	1.5e-06	19	48.7	39	31	154
Hematologic cancer (Various tumors)	Various tumors	1.5e-06	19	48.7	39	31	154
Primary blood mononuclear cells (Various tumors)	Various tumors	1.5e-06	19	48.7	39	31	154
Cell line (B lymphoma)	B lymphoma	1.5e-06	8	38.0	21	14	245
Hematologic samples and cell lines (Various tumors)	Various tumors	1.8e-06	21	53.8	39	37	154
Hematologic samples (Various tumors)	Various tumors	1.8e-06	21	53.8	39	37	154
Invasive liver tumor (Liver cancer)	Liver cancer	3.4e-06	18	47.3	38	38	207
Acute myelogeous leukemia (Leukemia)	Leukemia	4.1e-06	24	68.5	35	50	141
B cells (Various tumors)	Various tumors	1.1e-05	15	38.4	39	23	154
Non-classic anaplastic oligodendroglioma (Gliomas)	Gliomas	1.2e-05	13	100	13	13	20
Liver cancer cell line (Liver cancer)	Liver cancer	2.2e-05	8	21.0	38	10	207
Gram negative bacteria stimulated immune cells (Stimulated PBMC)	Stimulated PBMC	3.0e-05	19	95	20	78	144
B. petrussis A2 stimulated immune cells (Stimulated PBMC)	Stimulated PBMC	3.2e-05	5	25	20	5	144
B. petrussis Tox 6 stimulated immune cells (Stimulated PBMC)	Stimulated PBMC	3.2e-05	5	25	20	5	144
Liver tissue, cancer or cell line (Liver cancer*)	Liver cancer*	4.7e-05	34	19.7	172	197	1945
Lymphoma (Various tumors)	Various tumors	6.3e-05	13	33.3	39	20	154
p53 positive hepatocellular carcinoma (Liver cancer)	Liver cancer	6.3e-05	13	81.2	16	23	60
Follicular lymphoma (Various tumors)	Various tumors	6.8e-05	8	20.5	39	9	154
Cell line (Liver cancer)	Liver cancer	7.1e-05	8	21.0	38	11	207
Non-tumor liver tissue (Liver cancer)	Liver cancer	0.0001	23	65.7	35	76	207
Normal tissue (Lung cancer)	Lung cancer	0.0001	21	13.5	155	23	276
Lymphoma or lymphoma cell line (B lymphoma)	B lymphoma	0.0002	21	100	21	167	245
Normal lung tissue (Lung cancer)	Lung cancer	0.0003	20	12.9	155	22	276
Primary blood mononuclear cells (B lymphoma)	B lymphoma	0.0003	6	28.5	21	14	245

Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation	P-value	Hits	Hits(%)	Module genes	Genes in annotation	Genes
spliceosome complex	4.0e-05	7	3.4	202	23	4566
ribonucleoprotein complex	9.7e-05	27	13.3	202	283	4566

Visual display

Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.

You can also view the images within GeneXPress by loading the module gxp file file.

Note: Since there are 721 experiments, this image does not display the individual experiment names, but rather condenses each experiment to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above

>4x